Diabetic foot and lower limb amputations at tertiary hospitals underscore the need for organised foot health services at primary healthcare level

Authors

  • Tshepang Arthur Motsepe Department of General Surgery, Sefako Makgatho Health Sciences University and Dr. George Mukhari Academic Hospital, Pretoria
  • Andrew Machowski Department of General Surgery, Sefako Makgatho Health Sciences University and Dr. George Mukhari Academic Hospital, Pretoria
  • Shaan Marthinus Maritz Department of Clinical Services, Sefako Makgatho Health Sciences University and Dr. George Mukhari Academic Hospital, Pretoria

DOI:

https://doi.org/10.18203/2349-2902.isj20240599

Keywords:

Diabetic foot, Adjunctive, TIME principles, Mortality, Diabetes, Sepsis, Amputation

Abstract

An epidemiological link between diabetes and early mortality has been reported in literature with the cause of death being mainly ischaemic heart diseases. However, a diabetic foot is a common and serious complication of diabetes with a lifetime risk of developing a foot ulcer estimated at 15-25%. Therefore, local (foot disease) and systemic (cardiovascular disease) issues should be attended to in the management of diabetes, and this emphasizes the need for a multidisciplinary team approach. A diabetic foot is defined as worsening sepsis, ulcerations, necrosis or destruction of tissues of the foot in a diabetic patient due to a complex interaction of disorders in the immune function, in the nervous and vascular systems. An improved clinical outcome is associated with wound adjunctive treatments in complementing the standard management protocol which embodies the TIME principles (tissue debridement, infection control, adequate moisture balance to promote tissue granulation in the wound bed and edges of the wound should be free from undermining).

 

References

Chammas NK, Hill LR, Edmonds ME. Increased Mortality in Diabetic Foot Ulcer Patients: The Significance of Ulcer Type. J Diabetes Res. 2016;2879809:7.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and Treatment of Diabetic Foot Infections. Clin Infect Dis. 2004;39(7):885-910.

Vileikyte L. Diabetic foot ulcers: a quality-of-life issue. Diabetes Metab Res Rev. 2001;17:246-9.

Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Incidence and risk factors of Diabetic Foot Ulcer: A population-based Diabetic Foot Cohort (ADFC study)-two year follow up study. Int J Endocrinol. 2018;7631659:9.

Bekele F, Fekadu G, Bekele K, Dugassa D. Incidence of diabetic foot ulcer among diabetes mellitus patients admitted to Nekemte Referral Hospital, western Ethiopia: prospective observational study. Endocrinol Metab Syndr. 2019;8(2):300.

Schaper NC, Van Netten JJ, Apelqvis J, Bus SA, Hinchlife RJ, Lipsky BA. Part of the 2019 IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease. Diabetes Metab Res Rev. 2020;36(1):e3266.

Ramirez-Acuna JM, Cardenas-Cadena SA, Marquez-Salas PA, Garza-Veloz I, Perez-Favila A, Cid-Baez MA, et al. Diabetic Foot Ulcers: Current advances in antimicrobial therapies and emerging treatments. Antibiotics. 2019;8:193.

Quan D, Khardori R, Lin HC. What is the role of hyperglycemia in the pathophysiology of diabetic neuropathy? Medscape. Available at: https://www.medscape.com/answers/1170337-4901/what-is-the-role-of-hyperglycemia-in-the-pathophysiology-of-diabetic-neuropathy. Accessed on 10 January, 2024.

Vinik A, Casellini C, Nevoret ML. Diabetic Neuropathies. Diabetic Neuropathies. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000. Available at: https://www.ncbi.nlm.nih.gov/books/ NBK279175/. Accessed on 10 January, 2024.

Jacobs AM. A closer look at motor neuropathy in patients with diabetes. Podiatry Today. 2008;21(9).

Van Schie CH, Vermigli C, Carrington AL, Boulton A. Muscle Weakness and Foot Deformities in Diabetes. Diabetes Care. 2004;27(7):1668-73.

Pendsey SP. Understanding diabetic foot. Int J Diabetes Dev Ctries. 2010;30(2):75-9.

Stuart BM, Khardori R, Cunha BA. Diabetic foot infections. Emedicine.medscape.com. Available at: https://emedicine.medscape.com›237378-overview. Accessed on 10 January, 2024.

Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: Intensive Care Med. 2018;44(6):925-8.

Frykberg RG. Diabetic Foot Ulcers: Pathogenesis and Management. Am Fam Physician. 2002;66(9):1655-63.

Stang D, Young M. Selection and application of a diabetic foot ulcer classification system in Scotland: part 2. Diabet Foot J. 2018;21(2):100-5.

Mills JL, Conte MS, Armstrong DG. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg. 2014;59(1):220034.e1-2.

Ugwu E, Adeleye O, Gezawa I, Okpe I, Enamino M, Ezeani I. Predictors of lower extremity amputation in patients with diabetic foot ulcer: findings from MEDFUN, a multi-center observational study.J Foot Ankle Res. 2019;12:34.

Ntuli S, Letswalo DM. Diabetic foot and lower limb amputations at central, provincial and tertiary hospitals-underscores the need for organised foot health services at primary healthcare level. Foot (Edinb). 2023;56:102039.

Bowens S, Franco E. Chronic Wounds: Evaluation and Management. Am Fam Physician. 2020;101(3):159-66.

Downloads

Published

2024-02-29

Issue

Section

Review Articles